Zefamenib, CAS [[2938995-50-5]]

Product Overview

• Article Name: Zefamenib, CAS [[2938995-50-5]]
• Biozol Catalog Number: MCE-HY-153714
• Supplier Catalog Number: HY-153714
• Alternative Catalog Number: MCE-HY-153714-25MG,MCE-HY-153714-5MG,MCE-HY-153714-10MG,MCE-HY-153714-50MG,MCE-HY-153714-10MMX1ML,MCE-HY-153714-100MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: BN-104, BNM-1192, Menin-MLL inhibitor 27

Product Description

Zefamenib (BN-104) is an effective selective brain membrane protein inhibitor with oral activity, and its also a Menin inhibitor, it can block the Menin-MLL interaction and leads to the degradation of Menin protein. Zefamenib is a weak hERG inhibitor, with an IC50 greater than 100 µM. Zefamenib has anti-tumor activity and can be used in cancer research, such as for acute myeloid leukemia[1].

Product Properties

• Molecular Weight: 570.66
• Purity: 99.95
• CAS Number: [2938995-50-5]
• Formula: C31H35FN8O2
• Target: Epigenetic Reader Domain,Potassium Channel

Application Notes

• Application Notes: MCE Product type: Reference compound